Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK applications for sinus disease treatment accepted for review

(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP,...

LONDON MARKET CLOSE: FTSE 100 steady but Deepseek sparks US tech rout

(Alliance News) - London's blue-chips closed little changed on Monday amid a heavy sell-off in global technology stocks, including a 17% drop for chip...

GSK and University of Oxford researchers to create cancer vaccine

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing.

GSK shingles treatment application accepted for review in Europe

(Alliance News) - GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment for shingles.

LONDON BRIEFING: Diageo rules out Guinness sale; Dr Martens backs view

(Alliance News) - London's FTSE 100 is called to open lower on Monday, ahead of a slew of interest rate decisions this week, and as investors continue...

GSK's pre-filled shingles vaccine accepted for review by EMA

(Sharecast News) - GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the European M...

Swiss biopharma firm BioVersys plans IPO in first quarter

ZURICH, Jan 21 (Reuters) - Swiss biopharma company BioVersys said on Tuesday it plans to list on the Swiss stock exchange in the first quarter with ...

LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: